tirotropiini alfa - søkeresultat

Den europeiske union - norsk - EMA (European Medicines Agency)

thyrogen

sanofi b.v. - thyrotropin alfa - skjoldbrusk neoplasmer - fremre hypofysen lapp hormoner og analoger, hypofysen og hypothalamus hormoner og analoger - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Norge - norsk - Statens legemiddelverk

spiriva 18 mikrog

boehringer ingelheim international gmbh - tiotropiumbromid - inhalasjonspulver, hard kapsel - 18 mikrog

Norge - norsk - Statens legemiddelverk

spiriva respimat 2.5 mikrog

boehringer ingelheim international gmbh - tiotropiumbromid - inhalasjonsvæske, oppløsning - 2.5 mikrog

Norge - norsk - Statens legemiddelverk

tiogiva 18 mikrog

glenmark pharmaceuticals nordic ab - tiotropiumbromid - inhalasjonspulver, hard kapsel - 18 mikrog

Norge - norsk - Statens legemiddelverk

spiolto respimat 2.5 mikrog / 2.5 mikrog

boehringer ingelheim international gmbh - tiotropiumbromidmonohydrat / olodaterolhydroklorid - inhalasjonsvæske, oppløsning - 2.5 mikrog / 2.5 mikrog

Norge - norsk - Statens legemiddelverk

spiriva 18 mikrog